Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory Briefs: U.K. Trials Database; Hospitals Seek UDI Rule; FDA Workshops

This article was originally published in The Gray Sheet

Executive Summary

The U.K.’s National Health Service is requiring all U.K. trials to be registered in a clinical trial database. Five influential hospital systems urge the White House to release the UDI final rule. FDA schedules metabolic disease workshop. More regulatory news.

You may also be interested in...



$18.4 Million In User Fees Left In CDRH’s Coffers, How Long Will It Last?

The device center says it had $18.4 million in user fees remaining as of Oct. 1 to continue its work focused solely on user-fee funded activities, but the agency is unsure how long the funds will last if the government shutdown continues.

FDA Issues UDI Final Rule, Removes Direct Marking Requirement For Implants

The long-awaited unique device identifier final rule is intended to help FDA, device companies and health care providers track medical devices. The rule addresses many of industry’s concerns with FDA’s initial proposal and was met with general support by companies.

Regulatory Briefs: OMB Updates On UDI, eMDR Rule; Circ Panel Scheduled

Hospital groups meet with OMB on UDI rule. Electronic Medical Device Reporting final rule reaches OMB. More regulatory news.

Related Content

Topics

UsernamePublicRestriction

Register

OM007016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel